FDA clears bioMerieux's MRSA test

05/25/2011 | MedCityNews.com

The FDA has granted bioMerieux 510(k) clearance to market NucliSENS EasyQ MRSA, a molecular test that can spot seven types of methicillin-resistant Staphylococcus aureus. The test can process up to 46 samples and generate results in three hours.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC